Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 9:43 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1225–1248 of 13,937 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: HIV Infections
Interventions: Lamivudine/Zidovudine, Nelfinavir mesylate, Saquinavir, Delavirdine mesylate; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 16
States / cities: Menlo Park, California • Stanford, California • Denver, Colorado + 12 more

Conditions: Diabetes Mellitus
Interventions: CHW Training, Data Only; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 773 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Children
Interventions: LMA Proseal: control device, LMA Supreme: comparison device; Device
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 6 Months to 6 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Respiratory Therapist Education and Case Management; Other
Lead sponsor: StratiHealth; Industry
Eligibility: 55 Years to 80 Years
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Carlsbad, California

Conditions: Drug Abuse, Drug Dependence
Interventions: Prometa, Placebo; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Obesity, Overweight
Interventions: Behavioral Weight loss; Behavioral
Lead sponsor: California Polytechnic State University-San Luis Obispo; Other
Eligibility: 30 Years to 45 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: San Luis Obispo, California

Conditions: Carpal Tunnel Syndrome
Interventions: Societal cost; Other
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 89 Years
Enrollment: 184 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 6
States / cities: Austin, Texas

Conditions: Urinary Incontinence
Interventions: Academic Detailing, Electronic Clinical Decision Support, APP Co-management, Electronic Referral; Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 1,600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 4
States / cities: La Jolla, California • Los Angeles, California • Torrance, California

Conditions: Overweight, Obesity
Interventions: Tirzepatide, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 2,539 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 54
States / cities: Pelham, Alabama • Scottsdale, Arizona • Concord, California + 47 more

Conditions: Major Depressive Disorder
Interventions: Transcranial direct current stimulation, Sham Transcranial direct current stimulation; Device
Lead sponsor: Flow Neuroscience AB; Industry
Eligibility: 18 Years and older
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Study Focus: 30-day Rehospitalizations Among At-risk Older Adults Randomized to a Social Work-driven Care Transitions Intervention, Heart Disease, Diabetes, Hypertension, Cancer, Depression, Asthma, Chronic Heart Failure, Chronic Obstructive Pulmonary Disease, Stroke
Interventions: SWIFT home intervention; Other
Lead sponsor: University of Southern California; Other
Eligibility: 65 Years to 110 Years
Enrollment: 181 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 2
States / cities: Los Angeles, California • Pasadena, California

Conditions: Distal Radius Fracture
Interventions: Monetary Cost of Immobilization Treatments, Physician, Study Team, Before Initial Treatment Decision, After Initial Treatment Decision; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 4 Years to 14 Years
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Constipation, Post-Op Complication
Interventions: Polyethylene Glycol Powder; Drug
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Bay Shore, New York

Conditions: Pulmonary Disease, Chronic Obstructive, Pulmonary Diseases, Obstructive
Interventions: Automatic inclusion of COPD orders in admission orders, Dynamic, end-user order set design; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 310 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Total Knee Replacement
Interventions: Pain Neuroscience Education; Behavioral
Lead sponsor: University of Nevada, Las Vegas; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Insulin-like Growth Factor-1 Deficiency
Interventions: NutropinAq® (Somatropin [rDNA origin]), Increlex® (Mecasermin [rDNA origin] injection) + NutropinAq® (Somatropin [rDNA origin]); Drug
Lead sponsor: Ipsen; Industry
Eligibility: 5 Years and older
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Brisbane, California

Conditions: Liver Transplant; Complications, Vasoplegia
Interventions: Angiotensin II, Saline; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Schizophrenia, Schizoaffective Disorder, Substance Use Disorders
Interventions: Brexpiprazole, Treatment as Usual; Drug · Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 4
States / cities: Augusta, Georgia • Boston, Massachusetts • Worcester, Massachusetts + 1 more

Conditions: Inflammation at Mini-screw Insertion Site, Mobility, Mini-screw
Interventions: Amoxicillin, Placebo oral capsule; Drug
Lead sponsor: St. Louis University; Other
Eligibility: 12 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: HIV Infections
Interventions: Zidovudine; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older · Male only
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 1990
U.S. locations: 22
States / cities: Los Angeles, California • San Diego, California • San Francisco, California + 12 more

Conditions: Obesity and Type 2 Diabetes
Interventions: Behavioral Skill Training, Meal Provisioning; Behavioral · Other
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Influenza
Interventions: live attenuated and inactivated influenza vaccines; Biological
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 4 Years to 18 Years
Enrollment: 29,255 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2010
U.S. locations: 2
States / cities: Temple, Texas • Waco, Texas

Conditions: Telehealth at the Library, Control Group
Interventions: Library Telehealth with Buprenorphine Provider, Treatment-as-Usual Control group; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: San Diego, California

Conditions: Noninvasive Ventilation
Interventions: Head Rotation During Face Mask Ventilation, Medline Top Valve Anesthesia Mask; Procedure · Device
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Columbia, Missouri

Search by objective public record fields.

A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients

Integrating Community Health Workers to Improve Diabetes Prevention

A Comparison of the Laryngeal Mask Airway (LMA) Proseal and LMA Supreme in Children

Use of Respiratory Therapists (RTs) to Improve Outcomes and Quality of Life in Patients With COPD

Prometa Pharmacotherapy for Methamphetamine Dependence

Choose to Lose for Women-Weight Loss to Reduce Breast Cancer Risk Factors

Cost Information on Carpal Tunnel Syndrome Treatment Decisions

A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight

Empower: tDCS for Major Depressive Disorder at Home

Social Work Intervention Focused on Transitions

Distal Radius Buckle Fracture RCT

Does a Preoperative Bowel Regimen Change Time to First Bowel Movement After Robotic Sacral Colpopexy

Study of Automated Care Pathway for Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pain Neuroscience Education in Total Knee Arthroplasty

rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency

Angiotensin II in Liver Transplantation

Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder

Antibiotics Prior to Mini-screw Implant Insertion

A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

Investigating Metabolic and Psychological Adaptations in a Clinical Trial

Control of Epidemic Influenza Through a School-based Influenza Vaccination Program

"Bupe by the Book": Testing Library Telehealth With Unstably Housed Persons With Opioid Use Disorder

Effect of Head Rotation on Efficacy of Face Mask Ventilation in Anesthetized Obese (BMI ≥ 35) Adults